Filing Details
- Accession Number:
- 0001104659-25-021008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-05 18:33:49
- Reporting Period:
- 2025-03-03
- Filing Date:
- 2025-03-05
- Accepted Time:
- 2025-03-05 18:33:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1773427 | Springworks Therapeutics Inc. | SWTX | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1786966 | Badreddin Edris | C/O Springworks Therapeutics, Inc. 100 Washington Blvd. Stamford CT 06902 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-03-03 | 3,924 | $53.12 | 185,788 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-03 | 12,078 | $54.26 | 173,710 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-03 | 3,598 | $55.12 | 170,112 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-03 | 400 | $56.20 | 169,712 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on February 29, 2024.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.725 to $53.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.73 to $54.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.74 to $55.69. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.90 to $56.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Billionaire Hedge Funds
